Use code SAVEBIG to save big on memberships!

COVID-19 Antibodies Persist, Reduce Reinfection Risk For Up To Six Months

September 14, 2021

 • 

Read time:

5-15 mins
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
COVID Allergies Gatewayextension
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
Presented by Health Lab

A Michigan Medicine study found that mild COVID-19 infections create antibodies can protect patients from reinfection for almost six months. About ninety percent of participants produced antibody responses.

More from the Alumni Education Gateway
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.